World Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical TrialBy Marie JonesFebruary 11, 2021 Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has…